ECM

Endurant Capital Management Portfolio holdings

AUM $17.4M
1-Year Est. Return 4.95%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+4.95%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$111M
AUM Growth
+$33.8M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
58
New
Increased
Reduced
Closed

Top Buys

1
+$12M
2
+$7.01M
3
+$5.98M
4
AVTR icon
Avantor
AVTR
+$4.78M
5
CNMD icon
CONMED
CNMD
+$4.23M

Top Sells

1
+$7.86M
2
+$5.65M
3
+$5.5M
4
BDX icon
Becton Dickinson
BDX
+$3.53M
5
CAH icon
Cardinal Health
CAH
+$3M

Sector Composition

1 Healthcare 94.79%
2 Real Estate 4.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PODD icon
26
Insulet
PODD
$18B
$1.42M 1.27%
+8,878
ETNB
27
DELISTED
89bio
ETNB
$1.27M 1.14%
82,153
+52,871
HOLX icon
28
Hologic
HOLX
$16.7B
$1.23M 1.11%
+17,750
OCUL icon
29
Ocular Therapeutix
OCUL
$1.95B
$1.11M 1%
353,707
-14,731
AZTA icon
30
Azenta
AZTA
$1.79B
$975K 0.88%
+19,422
TARS icon
31
Tarsus Pharmaceuticals
TARS
$2.74B
$847K 0.76%
+47,649
AHCO icon
32
AdaptHealth
AHCO
$1.36B
$818K 0.74%
+89,937
AXSM icon
33
Axsome Therapeutics
AXSM
$9.29B
$787K 0.71%
+11,254
IQV icon
34
IQVIA
IQV
$39.2B
$776K 0.7%
3,946
-15,223
BLUE
35
DELISTED
bluebird bio
BLUE
$765K 0.69%
12,589
-1,483
OLMA icon
36
Olema Pharmaceuticals
OLMA
$2.06B
$723K 0.65%
58,573
+18,389
VTYX icon
37
Ventyx Biosciences
VTYX
$1B
$641K 0.58%
+18,458
ACLX icon
38
Arcellx
ACLX
$3.95B
$508K 0.46%
+14,158
GDRX icon
39
GoodRx Holdings
GDRX
$771M
$491K 0.44%
+87,290
RNAC icon
40
Cartesian Therapeutics
RNAC
$178M
$481K 0.43%
15,110
-7,761
TLT icon
41
iShares 20+ Year Treasury Bond ETF
TLT
$45.2B
$302K 0.27%
+3,400
NVST icon
42
Envista
NVST
$3.86B
$301K 0.27%
+10,787
ADAP
43
DELISTED
Adaptimmune Therapeutics
ADAP
$243K 0.22%
311,944
-509,094
EHC icon
44
Encompass Health
EHC
$9.51B
– –
-32,710
LH icon
45
Labcorp
LH
$22.5B
– –
-37,910
MASI icon
46
Masimo
MASI
$7.38B
– –
-2,850
MDT icon
47
Medtronic
MDT
$132B
– –
-27,181
QGEN icon
48
Qiagen
QGEN
$11.1B
– –
-59,137
SPY icon
49
State Street SPDR S&P 500 ETF Trust
SPY
$711B
– –
0
TEVA icon
50
Teva Pharmaceuticals
TEVA
$39.1B
– –
0
1
2
3